Information regarding HDA's history, leadership, mission, values and staff.
HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.
HDA President and CEO John M. Gray has outlined the organization’s priorities for the upcoming year in his annual “Pharmacy Outlook” column, published in the January 2 issue of Chain Drug Review.